ドクシミティの掲示板の投稿コメント詳細

“There’s a growing need for clinical tools that combine trusted evidence with the speed and adaptability of AI,” said Pathway CEO Jon Hershon. “Hundreds of thousands of users have registered for Pathway, and thousands pay $300 per year for our premium product. With Doximity, one of the most trusted platforms in healthcare, we’re now bringing that experience to millions for free, built directly into the tools they already use at the point of care.”

↑これmonetizeと反対の事しとるやん、、、
どうりで大して成長しないわけだね。